24/7 Market News Snapshot 30 September, 2025 – Qualigen Therapeutics, Inc. Common Stock (NASDAQ:QLGN)

September 30, 2025

DENVER, Colo., 30 September, 2025 (www.247marketnews.com) – (NASDAQ:QLGN) are discussed in this article.
In a notable financial development, Qualigen Therapeutics, Inc. (NASDAQ:QLGN) has experienced significant market activity, opening at $5.70 and currently trading at $5.71, a rise of over 6.13%. This bullish trend is accompanied by an impressive trading volume of 5.90 million shares, indicating robust investor interest and the potential for sustained momentum in the stock’s performance. Technical analyses suggest that maintaining above crucial support levels could pave the way for a rally toward resistance levels around $6.00. Market observers should closely monitor QLGN for potential breakout patterns and sentiment shifts within the biotechnology sector.

Further bolstering the company’s prospects, Qualigen has successfully secured a strategic investment totaling approximately $41 million, predominantly led by Faraday Future Intelligent Electric Inc. (NASDAQ:FFAI). This funding reflects a strong commitment to the development of innovative cancer therapies, supporting Qualigen’s ongoing efforts to create transformative treatments for some of the most challenging cancers. Faraday Future’s significant investment of around $30 million underscores their confidence in Qualigen’s potential, bolstered by YT Jia, the founder and Global Co-CEO of Faraday Future, who personally invested $4 million.

Qualigen’s key asset, the investigational QN-302 compound, shows promise in its ability to inhibit the proliferation of cancer cells, with particular focus on harsh forms impacting the pancreas, colon, and lungs. The partnership was highlighted during Faraday Future’s annual 919 Futurist Day, symbolizing a cooperative vision that merges healthcare innovation with technological advancements aimed at redefining oncology patient care. This strategic investment not only positions Qualigen for future growth but also enhances its capabilities in delivering effective treatment options for patients and families facing cancer.

Related news for (QLGN)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.